Skip to main content
. 2021 May 14;13(5):719. doi: 10.3390/pharmaceutics13050719

Table 1.

Identification of OLEA and its metabolites in lumen, plasma, and ileum tissue samples by LTQ–Orbitrap–MS.

Compound Precursor Ion Measured m/z [M − H] Tentative Formula [M − H] Mass Error (ppm) RT (min) MS/MS
M1 OLEA 319.1184 C17H19O6 0.785 6.81 153/183
Phase I
M2 OH-TY 153.0554 C8H9O3 0.779 3.67 123
M3 OLEA + H2 321.1337 C17H21O6 0.435 7.05 185/199/143
M4 OLEA + OH 335.1128 C17H19O7 0.271 6.82 131/199
M5 OLEA + H2O 337.1282 C17H21O7 0.021 6.69 201/133
Phase II
M6 OLEA + CH3 333.1348 C18H21O6 0.835 8.51 167
M7 OLEA + OH + CH3 349.1277 C18H21O7 −0.479 7.38 167/199
M8 OLEA + H2O + CH3 351.1445 C18H23O7 1.771 7.20 215/167
M9 OLEA + H2 + Glucu 497.1665 C23H29O12 1.247 6.53 199/329
M10 OLEA + H2O + Glucu 513.1621 C23H29O13 1.833 6.43 329/215
M11 OLEA + H2O + CH3 + Glucu 527.1743 C24H31O13 0.963 6.50 343/201

RT: retention time; Glucu: glucuronic acid; OH-TY: hydroxytyrosol.